Home LiteratureArticle Details
PMID: 28774341 Published · epublish English Journal Article Review

Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids.

Journal of experimental & clinical cancer research : CR ·Vol. 36 ·No. 1 ·2017-00-03 ·Pages 102

Riffle S, Hegde RS

Abstract

Under hypoxic conditions, tumor cells undergo a series of adaptations that promote evolution of a more aggressive tumor phenotype including the activation of DNA damage repair proteins, altered metabolism, and decreased proliferation. Together these changes mitigate the negative impact of oxygen deprivation and allow preservation of genomic integrity and proliferative capacity, thus contributing to tumor growth and metastasis. As a result the presence of a hypoxic microenvironment is considered a negative clinical feature of many solid tumors. Hypoxic niches in tumors also represent a therapeutically privileged environment in which chemo- and radiation therapy is less effective. Although the negative impact of tumor hypoxia has been well established, the precise effect of oxygen deprivation on tumor cell behavior, and the molecular signals that allow a tumor cell to survive in vivo are poorly understood. Multicellular tumor spheroids (MCTS) have been used as an in vitro model for the avascular tumor niche, capable of more accurately recreating tumor genomic profiles and predicting therapeutic response. However, relatively few studies have used MCTS to study the molecular mechanisms driving tumor cell adaptations within the hypoxic tumor environment. Here we will review what is known about cell proliferation, DNA damage repair, and metabolic pathways as modeled in MCTS in comparison to observations made in solid tumors. A more precise definition of the cell populations present within 3D tumor models in vitro could better inform our understanding of the heterogeneity within tumors as well as provide a more representative platform for the testing of therapeutic strategies.

Keywords
Cancer DNA Damage Repair Hypoxia Metabolism Multicellular Tumor Spheroids Proliferation
MeSH Terms
Cell Line, Tumor Cell Proliferation/drug effects Humans Spheroids, Cellular/metabolism
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Riffle Stephen
Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA.
Hegde Rashmi S
Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, 3333 Burnet Avenue, Cincinnati, OH, 45229, USA. Rashmi.hegde@cchmc.org.
References (142)
142 references, click to expand
  1. ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation.
    J Biol Chem. 2003 Apr 4;278(14 ):12207-13 PMID: 12519769
  2. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.
    Cancer Cell. 2005 Oct;8(4):299-309 PMID: 16226705
  3. Replication stress and chromatin context link ATM activation to a role in DNA replication.
    Mol Cell. 2013 Dec 12;52(5):758-66 PMID: 24268576
  4. Histone H2AX is integral to hypoxia-driven neovascularization.
    Nat Med. 2009 May;15(5):553-8 PMID: 19377486
  5. Advanced cell culture techniques for cancer drug discovery.
    Biology (Basel). 2014 May 30;3(2):345-67 PMID: 24887773
  6. Hypoxia promotes glycogen accumulation through hypoxia inducible factor (HIF)-mediated induction of glycogen synthase 1.
    PLoS One. 2010 Mar 12;5(3):e9644 PMID: 20300197
  7. A heterologous 3-D coculture model of breast tumor cells and fibroblasts to study tumor-associated fibroblast differentiation.
    Exp Cell Res. 2001 May 15;266(1):74-86 PMID: 11339826
  8. Methods: Using Three-Dimensional Culture (Spheroids) as an In Vitro Model of Tumour Hypoxia.
    Adv Exp Med Biol. 2016;899:167-96 PMID: 27325267
  9. Radiation and ATM inhibition: the heart of the matter.
    J Clin Invest. 2014 Aug;124(8):3289-91 PMID: 25036714
  10. Microenvironmental regulation of proliferation in multicellular spheroids is mediated through differential expression of cyclin-dependent kinase inhibitors.
    Cancer Res. 2004 Mar 1;64(5):1621-31 PMID: 14996720
  11. Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance.
    Cancer Res. 2008 Jan 15;68(2):605-14 PMID: 18199558
  12. Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer.
    BMC Cancer. 2012 Jan 13;12:15 PMID: 22244109
  13. "Contextual" synthetic lethality and/or loss of heterozygosity: tumor hypoxia and modification of DNA repair.
    Clin Cancer Res. 2010 Sep 15;16(18):4553-60 PMID: 20823145
  14. Phosphorylated histone H2AX in spheroids, tumors, and tissues of mice exposed to etoposide and 3-amino-1,2,4-benzotriazine-1,3-dioxide.
    Cancer Res. 2004 Aug 1;64(15):5363-9 PMID: 15289343
  15. Targeting radiation-resistant hypoxic tumour cells through ATR inhibition.
    Br J Cancer. 2012 Jul 10;107(2):291-9 PMID: 22713662
  16. The process of macrophage migration promotes matrix metalloproteinase-independent invasion by tumor cells.
    J Immunol. 2011 Oct 1;187(7):3806-14 PMID: 21880978
  17. Use of multicellular tumor spheroids to dissect endothelial cell-tumor cell interactions: a role for T-cadherin in tumor angiogenesis.
    FEBS Lett. 2007 Sep 18;581(23):4523-8 PMID: 17765896
  18. Fibroblast EXT1-levels influence tumor cell proliferation and migration in composite spheroids.
    PLoS One. 2012;7(7):e41334 PMID: 22848466
  19. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation.
    BMC Biol. 2012 Mar 22;10:29 PMID: 22439642
  20. Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia.
    Oncogene. 2007 Mar 29;26(14 ):2048-57 PMID: 17001309
  21. Impact of human bladder cancer cell architecture on autologous T-lymphocyte activation.
    Int J Cancer. 2002 Mar 1;98(1):51-6 PMID: 11857385
  22. Oxygen-Enhanced MRI Is a Major Advance in Tumor Hypoxia Imaging.
    Cancer Res. 2016 Feb 15;76(4):769-72 PMID: 26837768
  23. Multicellular tumor spheroid models to explore cell cycle checkpoints in 3D.
    BMC Cancer. 2013 Feb 08;13:73 PMID: 23394599
  24. Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids.
    Hepatology. 2010 Jun;51(6):2183-92 PMID: 20513003
  25. Monitoring the Activation of the DNA Damage Response Pathway in a 3D Spheroid Model.
    PLoS One. 2015 Jul 30;10(7):e0134411 PMID: 26225756
  26. Hypoxia-induced down-regulation of BRCA1 expression by E2Fs.
    Cancer Res. 2005 Dec 15;65(24):11597-604 PMID: 16357170
  27. Increased complexity in carcinomas: Analyzing and modeling the interaction of human cancer cells with their microenvironment.
    Semin Cancer Biol. 2015 Dec;35:107-24 PMID: 26320002
  28. Hypoglycemia Enhances Epithelial-Mesenchymal Transition and Invasiveness, and Restrains the Warburg Phenotype, in Hypoxic HeLa Cell Cultures and Microspheroids.
    J Cell Physiol. 2017 Jun;232(6):1346-1359 PMID: 27661776
  29. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment.
    Nature. 2009 Sep 3;461(7260):109-13 PMID: 19693011
  30. HIF-1 and HIF-2 transcription factors--similar but not identical.
    Mol Cells. 2010 May;29(5):435-42 PMID: 20396958
  31. Inhibition of ATR leads to increased sensitivity to hypoxia/reoxygenation.
    Cancer Res. 2004 Sep 15;64(18):6556-62 PMID: 15374968
  32. Energy metabolism transition in multi-cellular human tumor spheroids.
    J Cell Physiol. 2008 Jul;216(1):189-97 PMID: 18264981
  33. Gene expression analysis of tumor spheroids reveals a role for suppressed DNA mismatch repair in multicellular resistance to alkylating agents.
    Mol Cell Biol. 2004 Aug;24(15):6837-49 PMID: 15254249
  34. Three-dimensional cell culture induces novel proliferative and metabolic alterations associated with oncogenic transformation.
    Int J Cancer. 1996 May 16;66(4):578-86 PMID: 8635877
  35. Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.
    Mol Cell Biol. 2004 Oct;24(19):8504-18 PMID: 15367671
  36. Multicellular tumor spheroids: an underestimated tool is catching up again.
    J Biotechnol. 2010 Jul 1;148(1):3-15 PMID: 20097238
  37. Regulation of growth saturation and development of necrosis in EMT6/Ro multicellular spheroids by the glucose and oxygen supply.
    Cancer Res. 1986 Jul;46(7):3504-12 PMID: 3708582
  38. The role of the HIF-1α transcription factor in increased cell division at physiological oxygen tensions.
    PLoS One. 2014 May 16;9(5):e97938 PMID: 24835245
  39. Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer.
    Cell Death Dis. 2017 Feb 2;8(2):e2593 PMID: 28151470
  40. Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy.
    J Transl Med. 2006 Mar 02;4:12 PMID: 16509995
  41. Ribonucleotide Reductase Requires Subunit Switching in Hypoxia to Maintain DNA Replication.
    Mol Cell. 2017 Apr 20;66(2):206-220.e9 PMID: 28416140
  42. A novel radiotracer to image glycogen metabolism in tumors by positron emission tomography.
    Cancer Res. 2014 Mar 1;74(5):1319-28 PMID: 24590807
  43. Drug penetration in solid tumours.
    Nat Rev Cancer. 2006 Aug;6(8):583-92 PMID: 16862189
  44. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation.
    J Immunol. 2005 Jan 1;174(1):215-22 PMID: 15611243
  45. Reductive carboxylation supports redox homeostasis during anchorage-independent growth.
    Nature. 2016 Apr 14;532(7598):255-8 PMID: 27049945
  46. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability.
    Nat Rev Cancer. 2008 Mar;8(3):180-92 PMID: 18273037
  47. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability.
    Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19611-6 PMID: 22106302
  48. Cancer Stem Cells and Their Microenvironment: Biology and Therapeutic Implications.
    Stem Cells Int. 2017;2017:3714190 PMID: 28337221
  49. Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis, and proliferation.
    Am J Clin Oncol. 2001 Oct;24(5):467-72 PMID: 11586098
  50. Hallmarks of cancer: the next generation.
    Cell. 2011 Mar 4;144(5):646-74 PMID: 21376230
  51. Staining Against Phospho-H2AX (γ-H2AX) as a Marker for DNA Damage and Genomic Instability in Cancer Tissues and Cells.
    Adv Exp Med Biol. 2016;899:1-10 PMID: 27325258
  52. Cell cycle and apoptotic effects of SAHA are regulated by the cellular microenvironment in HCT116 multicellular tumour spheroids.
    Eur J Cancer. 2009 Sep;45(13):2402-11 PMID: 19553104
  53. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy.
    J Control Release. 2012 Dec 10;164(2):192-204 PMID: 22613880
  54. Hypoxia and cellular metabolism in tumour pathophysiology.
    J Physiol. 2017 Apr 15;595(8):2439-2450 PMID: 28074546
  55. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis.
    Cancer Cell. 2009 Mar 3;15(3):220-31 PMID: 19249680
  56. The meaning, measurement and modification of hypoxia in the laboratory and the clinic.
    Clin Oncol (R Coll Radiol). 2014 May;26(5):277-88 PMID: 24602562
  57. Functional interaction between responses to lactic acidosis and hypoxia regulates genomic transcriptional outputs.
    Cancer Res. 2012 Jan 15;72(2):491-502 PMID: 22135092
  58. ATM activation and signaling under hypoxic conditions.
    Mol Cell Biol. 2009 Jan;29(2):526-37 PMID: 18981219
  59. Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery.
    Sci Rep. 2016 Jul 01;6:28951 PMID: 27364600
  60. Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells.
    Cell Metab. 2012 Dec 5;16(6):751-64 PMID: 23177934
  61. HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression.
    Mol Cell. 2005 Mar 18;17(6):793-803 PMID: 15780936
  62. Anchorage-independent multi-cellular spheroids as an in vitro model of growth signaling in Ewing tumors.
    Oncogene. 2002 Jan 10;21(2):307-18 PMID: 11803474
  63. Immunohistochemical expression of stem cell, endothelial cell, and chemosensitivity markers in primary glioma spheroids cultured in serum-containing and serum-free medium.
    Neurosurgery. 2010 May;66(5):933-47 PMID: 20404698
  64. Hypoxia links ATR and p53 through replication arrest.
    Mol Cell Biol. 2002 Mar;22(6):1834-43 PMID: 11865061
  65. Glioma: experimental models and reality.
    Acta Neuropathol. 2017 Feb;133(2):263-282 PMID: 28074274
  66. Stromal cells in tumor microenvironment and breast cancer.
    Cancer Metastasis Rev. 2013 Jun;32(1-2):303-15 PMID: 23114846
  67. Spontaneously-forming spheroids as an in vitro cancer cell model for anticancer drug screening.
    Oncotarget. 2015 Aug 28;6(25):21255-67 PMID: 26101913
  68. Harnessing synthetic lethal interactions in anticancer drug discovery.
    Nat Rev Drug Discov. 2011 May;10(5):351-64 PMID: 21532565
  69. Multiparameter analyses of three-dimensionally cultured tumor spheroids based on respiratory activity and comprehensive gene expression profiles.
    Anal Biochem. 2013 Aug 15;439(2):187-93 PMID: 23628321
  70. Cancer metabolism: facts, fantasy, and fiction.
    Biochem Biophys Res Commun. 2004 Jan 16;313(3):459-65 PMID: 14697210
  71. Liquid-based three-dimensional tumor models for cancer research and drug discovery.
    Exp Biol Med (Maywood). 2016 May;241(9):939-54 PMID: 27072562
  72. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects.
    J Natl Cancer Inst. 2001 Feb 21;93(4):266-76 PMID: 11181773
  73. Escaping Antiangiogenic Therapy: Strategies Employed by Cancer Cells.
    Int J Mol Sci. 2016 Sep 06;17 (9): PMID: 27608016
  74. A multicellular 3D heterospheroid model of liver tumor and stromal cells in collagen gel for anti-cancer drug testing.
    Biochem Biophys Res Commun. 2013 Apr 12;433(3):327-32 PMID: 23501105
  75. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis.
    Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):768-72 PMID: 7531342
  76. The pentose phosphate pathway: an antioxidant defense and a crossroad in tumor cell fate.
    Free Radic Biol Med. 2012 Aug 1;53(3):421-36 PMID: 22580150
  77. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species.
    FASEB J. 2003 Mar;17(3):503-5 PMID: 12514119
  78. Linking hypoxia, DNA damage and proliferation in multicellular tumor spheroids.
    BMC Cancer. 2017 May 18;17 (1):338 PMID: 28521819
  79. The rate of oxygen utilization by cells.
    Free Radic Biol Med. 2011 Aug 1;51(3):700-12 PMID: 21664270
  80. Antiangiogenic therapy for cancer: an update.
    Pharmacotherapy. 2012 Dec;32(12):1095-111 PMID: 23208836
  81. Penetration of anticancer drugs through tumour tissue as a function of cellular packing density and interstitial fluid pressure and its modification by bortezomib.
    BMC Cancer. 2012 Jun 06;12:214 PMID: 22672469
  82. Endogenous and radiation-induced expression of gammaH2AX in biopsies from patients treated for carcinoma of the uterine cervix.
    Radiother Oncol. 2010 Jan;94(1):82-9 PMID: 19903578
  83. From 3D cell culture to organs-on-chips.
    Trends Cell Biol. 2011 Dec;21(12):745-54 PMID: 22033488
  84. Transcriptome profile of the early stages of breast cancer tumoral spheroids.
    Sci Rep. 2016 Mar 29;6:23373 PMID: 27021602
  85. Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels.
    Nat Commun. 2012 Apr 17;3:783 PMID: 22510688
  86. Mathematical modelling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites.
    J Theor Biol. 2004 Feb 21;226(4):377-91 PMID: 14759644
  87. Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment.
    Oncotarget. 2017 Jan 3;8(1):1725-1736 PMID: 27965457
  88. Metabolic alterations during the growth of tumour spheroids.
    Cell Biochem Biophys. 2014 Apr;68(3):615-28 PMID: 24037715
  89. Pathological neoangiogenesis depends on oxidative stress regulation by ATM.
    Nat Med. 2012 Aug;18(8):1208-16 PMID: 22797809
  90. Macrophages promote angiogenesis in human breast tumour spheroids in vivo.
    Br J Cancer. 2006 Jan 16;94(1):101-7 PMID: 16404363
  91. Advances in the formation, use and understanding of multi-cellular spheroids.
    Expert Opin Biol Ther. 2012 Oct;12(10):1347-60 PMID: 22784238
  92. IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives.
    Clin Cancer Res. 2012 Oct 15;18(20):5562-71 PMID: 23071358
  93. A method for estimating the oxygen consumption rate in multicellular tumour spheroids.
    J R Soc Interface. 2014 Jan 15;11(92):20131124 PMID: 24430128
  94. A three-dimensional in vitro model of tumor cell intravasation.
    Integr Biol (Camb). 2014 Jun;6(6):603-10 PMID: 24763498
  95. Tumor-induced angiogenesis studied in confrontation cultures of multicellular tumor spheroids and embryoid bodies grown from pluripotent embryonic stem cells.
    FASEB J. 2001 Apr;15(6):995-1005 PMID: 11292660
  96. 3D imaging of the response to CDC25 inhibition in multicellular spheroids.
    Cancer Biol Ther. 2009 Dec;8(23):2230-36 PMID: 19823027
  97. Spheroids: relation between tumour and endothelial cells.
    Crit Rev Oncol Hematol. 2000 Nov-Dec;36(2-3):99-106 PMID: 11033300
  98. Tumor-derived spheroids: Relevance to cancer stem cells and clinical applications.
    Cancer Sci. 2017 Mar;108(3):283-289 PMID: 28064442
  99. Formation and repair of oxidatively generated damage in cellular DNA.
    Free Radic Biol Med. 2017 Jun;107:13-34 PMID: 28057600
  100. Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues.
    J Cell Sci. 2012 Jul 1;125(Pt 13):3015-24 PMID: 22797912
  101. ROS homeostasis and metabolism: a critical liaison for cancer therapy.
    Exp Mol Med. 2016 Nov 4;48(11):e269 PMID: 27811934
  102. Hypoxia and metabolic adaptation of cancer cells.
    Oncogenesis. 2016 Jan 25;5:e190 PMID: 26807645
  103. Cell and environment interactions in tumor microregions: the multicell spheroid model.
    Science. 1988 Apr 8;240(4849):177-84 PMID: 2451290
  104. Targeting hypoxia in cancer therapy.
    Nat Rev Cancer. 2011 Jun;11(6):393-410 PMID: 21606941
  105. 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing.
    BMC Cancer. 2013 Feb 27;13:95 PMID: 23446043
  106. Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, and MCT4) expression in human adipocytes.
    Pflugers Arch. 2010 Feb;459(3):509-18 PMID: 19876643
  107. Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma.
    BMC Cancer. 2015 Jun 10;15:462 PMID: 26054341
  108. Brave little world: spheroids as an in vitro model to study tumor-immune-cell interactions.
    Cell Cycle. 2006 Apr;5(7):691-5 PMID: 16582627
  109. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression.
    Blood. 2006 Mar 1;107(5):2013-21 PMID: 16278308
  110. Tissue mechanics promote IDH1-dependent HIF1α-tenascin C feedback to regulate glioblastoma aggression.
    Nat Cell Biol. 2016 Dec;18(12 ):1336-1345 PMID: 27820599
  111. Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids.
    Sci Rep. 2016 Nov 17;6:36750 PMID: 27853186
  112. ATM activation in hypoxia - causes and consequences.
    Mol Cell Oncol. 2014 Jul 28;1(1):e29903 PMID: 27308313
  113. Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment.
    DNA Repair (Amst). 2015 Aug;32:180-9 PMID: 25956861
  114. Role of tumor microenvironment in tumorigenesis.
    J Cancer. 2017 Feb 25;8(5):761-773 PMID: 28382138
  115. Generation of multicellular tumor spheroids by the hanging-drop method.
    Methods Mol Med. 2007;140:141-51 PMID: 18085207
  116. Cell surface oxygen consumption: a major contributor to cellular oxygen consumption in glycolytic cancer cell lines.
    Biochim Biophys Acta. 2007 Feb;1767(2):170-7 PMID: 17266920
  117. On the relation between size of necrosis and diameter of tumor spheroids.
    Int J Radiat Oncol Biol Phys. 1996 Jan 15;34(2):395-401 PMID: 8567341
  118. Spherical cancer models in tumor biology.
    Neoplasia. 2015 Jan;17(1):1-15 PMID: 25622895
  119. Three-dimensional neuroblastoma cell culture: proteomic analysis between monolayer and multicellular tumor spheroids.
    Pediatr Surg Int. 2008 Nov;24(11):1229-34 PMID: 18797883
  120. Contextual synthetic lethality of cancer cell kill based on the tumor microenvironment.
    Cancer Res. 2010 Oct 15;70(20):8045-54 PMID: 20924112
  121. Effects of acute versus chronic hypoxia on DNA damage responses and genomic instability.
    Cancer Res. 2010 Feb 1;70(3):925-35 PMID: 20103649
  122. A heterogeneous in vitro three dimensional model of tumour-stroma interactions regulating sprouting angiogenesis.
    PLoS One. 2012;7(2):e30753 PMID: 22363483
  123. Radiosensitization of hypoxic cells of an in vitro tumor model by respiratory inhibitors.
    Radiat Res. 1977 Feb;69(2):359-66 PMID: 14354
  124. Three-dimensional culture of melanoma cells profoundly affects gene expression profile: a high density oligonucleotide array study.
    J Cell Physiol. 2005 Aug;204(2):522-31 PMID: 15744745
  125. Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance.
    Oncogene. 2007 Mar 29;26(14 ):2027-38 PMID: 17043658
  126. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia.
    Nature. 2011 Nov 20;481(7381):380-4 PMID: 22101433
  127. The Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and Progression.
    Oxid Med Cell Longev. 2016;2016:3907147 PMID: 26798421
  128. Spheroid-based drug screen: considerations and practical approach.
    Nat Protoc. 2009;4(3):309-24 PMID: 19214182
  129. On respiratory impairment in cancer cells.
    Science. 1956 Aug 10;124(3215):267-9 PMID: 13351638
  130. gammaH2AX expression in tumors exposed to cisplatin and fractionated irradiation.
    Clin Cancer Res. 2009 May 15;15(10):3344-53 PMID: 19401347
  131. The Eyes Absent Proteins in Developmental and Pathological Angiogenesis.
    Am J Pathol. 2016 Mar;186(3):568-78 PMID: 26765957
  132. Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome.
    Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1024-31 PMID: 17967299
  133. Multicellular tumor spheroids from human gliomas maintained in organ culture.
    J Neurosurg. 1990 Mar;72(3):463-75 PMID: 2406382
  134. Down-regulation of DNA mismatch repair enhances initiation and growth of neuroblastoma and brain tumour multicellular spheroids.
    PLoS One. 2011;6(12 ):e28123 PMID: 22145025
  135. The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study.
    Transl Oncol. 2010 Jun 01;3(3):160-9 PMID: 20563257
  136. An integrated in vitro model of perfused tumor and cardiac tissue.
    Stem Cell Res Ther. 2013;4 Suppl 1:S15 PMID: 24565445
  137. Drug and radiation resistance in spheroids: cell contact and kinetics.
    Cancer Metastasis Rev. 1994 Jun;13(2):121-38 PMID: 7923546
  138. Targeting hypoxic cells through the DNA damage response.
    Clin Cancer Res. 2010 Dec 1;16(23):5624-9 PMID: 20876254
  139. Human mesenchymal stromal cell-secreted lactate induces M2-macrophage differentiation by metabolic reprogramming.
    Oncotarget. 2016 May 24;7(21):30193-210 PMID: 27070086
  140. Redox regulation of P-glycoprotein-mediated multidrug resistance in multicellular prostate tumor spheroids.
    Int J Cancer. 2000 Jan 15;85(2):267-74 PMID: 10629088
  141. Influence of glucose concentration on growth and formation of necrosis in spheroids derived from a human bladder cancer cell line.
    Cancer Res. 1986 Jun;46(6):3105-10 PMID: 3516390
  142. Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr.
    Radiat Oncol. 2011 Nov 11;6:156 PMID: 22077956
Article Info
Journal
Journal of experimental & clinical cancer research : CR
Abbr.
J Exp Clin Cancer Res
ISSN
1756-9966
Published
2017-00-03
Epub
2017-00-03
Pages
102
Language
English
Region
England
NLM ID
8308647
PMCID
PMC5543535
Subset
IM
Grants
NCI NIH HHS · R01 CA207068 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com